Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Lessons Learnt From the MINERVA Project in Europe.

Autor: Gini R; Agenzia Regionale di Sanità Della Toscana, Florence, Italy., Pajouheshnia R; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain., Gutierrez L; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain., Swertz MA; Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands., Hyde E; Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands., Sturkenboom M; Department of Datascience and Biostatistics, University Medical Centre Utrecht, Utrecht, The Netherlands., Arana A; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain., Franzoni C; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain., Ehrenstein V; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Roberto G; Agenzia Regionale di Sanità Della Toscana, Florence, Italy., Gil M; Base de Datos Para la Investigación Farmacoepidemiológica en Atención Primaria, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain., Maciá MA; Base de Datos Para la Investigación Farmacoepidemiológica en Atención Primaria, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain., Schäfer W; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany., Haug U; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany.; Faculty of Human and Health Science, University of Bremen, Bremen, Germany., Thurin NH; Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France., Lassalle R; Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France., Droz-Perroteau C; Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France., Zaccagnino S; European Society for Blood & Marrow Transplantation, Leiden, The Netherlands., Busto MP; European Society for Blood & Marrow Transplantation, Leiden, The Netherlands., Middelkoop B; European Society for Blood & Marrow Transplantation, Leiden, The Netherlands., Gembert K; Department of Epidemiology, Karolinska Institutet, Stockholm, Sweden., Sanchez-Saez F; Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain., Rodriguez-Bernal C; Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain., Sanfélix-Gimeno G; Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain., Hurtado I; Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain., Acosta MB; Spanish Working Group on Crohn's Disease and Ulcerative Colitis, Bilbao, Spain., Poblador-Plou B; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain., Carmona-Pírez J; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.; Technical Advisory Subdirectorate of Information Management (STAGI), Andalusian Health Service (SAS), Seville, Spain., Gimeno-Miguel A; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain., Prados-Torres A; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain., Schultze A; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK., Jansen E; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Herings R; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Kuiper J; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Locatelli I; University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia., Jazbar J; University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia., Žerovnik Š; University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia., Kos M; University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia., Smit S; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Lind S; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Metspalu A; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Simou S; European Medicines Agency, Amsterdam, The Netherlands., Hedenmalm K; European Medicines Agency, Amsterdam, The Netherlands., Cochino A; European Medicines Agency, Amsterdam, The Netherlands., Alcini P; European Medicines Agency, Amsterdam, The Netherlands., Kurz X; European Medicines Agency, Amsterdam, The Netherlands., Perez-Gutthann S; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.
Jazyk: angličtina
Zdroj: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Aug; Vol. 33 (8), pp. e5884.
DOI: 10.1002/pds.5884
Databáze: MEDLINE